A nationwide recall has been issued for a common pain medication due to dosage issues, Health Canada says.
One lot of bottled JAMP-Pregabalin 50 milligram capsules may mistakenly contain 150 milligram capsules, which could lead to overdose and potentially cause serious or fatal health risks, the May 3 recall notice said.
The affected lot of JAMP-Pregabalin 50 milligram capsules is from lot number 2305012747, has drug identification number (DIN) 02435985, and an expiry date of August 2026.
JAMP-Pregabalin is a pain medication prescribed to adults to treat pain caused by nerve damage from diabetes, shingles, or spinal cord injuries. It is also prescribed for pain associated with fibromyalgia….